Epidermal Growth Factor Receptor Inhibitor Database
|
|
|
|
|
|
|
|
|
|
|
| Experimental Information | |
| Enzymatic Activity | |
| Molecule Id | EGIN0003000 |
| PMID | 20456957 |
| Assay Used | RTK-ELISA-assay and Cell proliferation and toxicity assay |
| Experimently Validated | Yes |
| EGFR (IC50) | 1250 ± 130 nM |
| HER2 (IC50) | - |
| HER4 (IC50) | - |
| Mutant L858R (IC50) | - |
| Mutant T790M (IC50) | - |
| Double Mutant (IC50) | - |
| Average ERBB2 and ERBB1 (IC50) | - |
| Inhibition EGFR (%) | - |
| Inhibitory Concentration | - |
| Inhibition HER2 (%) | - |
| Inhibitory Concentration | - |
| Ki (EGFR) | - |
| Ki (HER2) | - |
| Ki (HER4) | - |
| Kd (EGFR) | - |
| Kd (L858R) | - |
| Kd (T790M) | - |
| Kd (L858R/T790M) | - |
| Kd (Other mutation) | - |
| Note | The paper describes the serotonin based non-ATP competitive RTK inhibitors |
| Extra | - |
| Cellular Activity | ||||||||||||||
| S.No. | Cell Line | Desp. | IC50 | IC80 | ED50 | GI50 | GI90 | EC50 | Kd | Inhibition (%) | Inhibitory Conc. | |||
| 1 | HEPM | Prolifieration | 2530 ±600 nM | - | - | - | - | - | - | - | - | |||
| 2 | HEPM | Cytotoxicity | 5700 ±600 nM | - | - | - | - | - | - | - | - | |||
| 3 | HT29 | Prolifieration | 4860 ±100 nM | - | - | - | - | - | - | - | - | |||
| 4 | HT29 | Cytotoxicity | 8500 ±300 nM | - | - | - | - | - | - | - | - | |||
| 5 | HUVEC | Prolifieration | 750 ±200 nM | - | - | - | - | - | - | - | - | |||
| 6 | HUVEC | Cytotoxicity | 3450 ±2900 nM | - | - | - | - | - | - | - | - | |||
| 7 | MCF-7 | Prolifieration | 4790 ±100 nM | - | - | - | - | - | - | - | - | |||
| 8 | MCF-7 | Cytotoxicity | 4930 ±500 nM | - | - | - | - | - | - | - | - | |||
| Activity against Receptor | |
| EGFR | Yes |
| HER2 | - |
| HER4 | - |
| Wild type | Yes |
| Mutant | - |
| Inhibitor Binding | |
| EGFR | - |
| HER2 | - |
| HER4 | - |